Pure red cell aplasia due to persistent B19 parvovirus infection in patient infected with human immunodeficiency virus type 1. Recovery with alpha‐interferon therapy

• Autor(a) principal: MARTINS, A.
• Data de Publicação: 1998
• Outros Autores: COSTA, A., OLIVEIRA, M., RODRIGUES, M., RIBEIRO, A., SILVESTRE, F., REIS, A.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.16/835

Sangre (Barc). 1998 Feb;43(1):67-9. Pure red cell aplasia due to persistent B19 parvovirus infection in patient infected with human immunodeficiency virus type 1. Recovery with alpha-interferon therapy. Martins A, Costa A, Oliveira MJ, Rodrigues M, Ribeiro AP, Silvestre F, Reis A. SourceMedicine (Medicina 1 and Haematology Services) Department, Hospital Geral de Santo Antonio, Porto, Portugal. Abstract B19 parvovirus (PV) infection is ordinarily resolved with the production of specific antibodies that neutralize virus infectivity for erythroid host cells. Nevertheless persistent infection with B19 PV and pure red blood cell aplasia have been documented. A 27 year-old male. i.v. drug abuser, HIV+ and HCV was diagnosed of pure red cell aplasia. Six months later we had serologic evidence of persistent parvovirus infection. Interferon therapy, started for HCV infection, showed a marked improvement of anaemia and anti parvovirus IgM became negative. It is discussed the possible role of interferon therapy in persistent parvovirus infection. PMID:9577184[PubMed - indexed for MEDLINE]